Good question, and hard to answer. RGBP is not even worth 0.004. (I typed this up yesterday, and already we are under that!) Having said that, pink sheet hype/mania drove this up to 8 cents. That is insanity. Trying to predict the actions of irrational pink sheet investors is impossible.
Investing is not about buying a stock, getting lucky that a PR comes out that drives a bunch of people who don't understand investing, to drive up the price, and then sell out. Instead its about building a quality reputable company with products, and in the case of drugs, where the scientific community acknowledges the science (not people you hire), resulting in gains over many years and many times the value of the stock.
This is in effect, a one person company, and that one person has zero credibility and has done nothing but run other pink sheet companies into the ground. Anyone who wants to debate that can put up the financials of his prior companies and show me where I am wrong!!
Pink sheet investors fail to understand that a patent means nothing as are as quality or usefulness of the product! Even if they have 29 patents, or whatever the total is now!
All that being said. How can I predict a short term bottom or move? What I can say is there is no question RGBP will never get bought out and will NEVER have an approved drug. Not maybe, NEVER! So 0.0025 is coming, and triple digits is coming.
I can also tell you that RGBP can easily double in a couple of days. Does that sound good? Is it going to double from 0.003? 0.002? 0.001? Those moves will be as meaningless, in the longer term, as the year end double was.
No easy answers in predicting how pink sheet investors act, but in the long run, this is still over priced!
News 
Market Data 
Discover 
